NCT05761847 Pediatric Medication Therapy Management Trial
| NCT ID | NCT05761847 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Colorado, Denver |
| Condition | Child, Only |
| Study Type | INTERVENTIONAL |
| Enrollment | 371 participants |
| Start Date | 2023-09-11 |
| Primary Completion | 2027-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 371 participants in total. It began in 2023-09-11 with a primary completion date of 2027-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate whether an intervention called Pediatric Medication Therapy Management (pMTM) improves the identification and management of medication-related problems among children with medical complexity and polypharmacy.
Eligibility Criteria
Inclusion Criteria: * 2-18 years old * ≥1 complex chronic condition (CCC) * ≥5 current medications (including prescription, as needed, and over-the-counter medications) * Receives primary care at Children's Hospital Colorado Exclusion Criteria: * Non-English speaking * Sibling or family member already enrolled in this study
Contact & Investigator
James A Feinstein, MD, MPH
PRINCIPAL INVESTIGATOR
University of Colorado, Denver
Frequently Asked Questions
Who can join the NCT05761847 clinical trial?
This trial is open to participants of all sexes, aged 2 Years or older, up to 18 Years, studying Child, Only. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05761847 currently recruiting?
Yes, NCT05761847 is actively recruiting participants. Contact the research team at james.feinstein@cuanschutz.edu for enrollment information.
Where is the NCT05761847 trial being conducted?
This trial is being conducted at Aurora, United States.
Who is sponsoring the NCT05761847 clinical trial?
NCT05761847 is sponsored by University of Colorado, Denver. The principal investigator is James A Feinstein, MD, MPH at University of Colorado, Denver. The trial plans to enroll 371 participants.